Terconazole
- Generic Name
- Terconazole
- Brand Names
- Terazol 3
- Drug Type
- Small Molecule
- Chemical Formula
- C26H31Cl2N5O3
- CAS Number
- 67915-31-5
- Unique Ingredient Identifier
- 0KJ2VE664U
Overview
Terconazole is an anti-fungal drug that is mainly used to treat vaginal yeast infections (or vaginal candidiasis). It is classified as a triazole ketal derivative. Terconazole was initially approved by the FDA in 1987. This drug is available in cream and suppository forms and both have demonstrated high levels of safety, efficacy, and tolerability in clinical trials. Due to the existence of 2 stereocentres, there are 4 possible stereoisomers for terconazole.
Background
Terconazole is an anti-fungal drug that is mainly used to treat vaginal yeast infections (or vaginal candidiasis). It is classified as a triazole ketal derivative. Terconazole was initially approved by the FDA in 1987. This drug is available in cream and suppository forms and both have demonstrated high levels of safety, efficacy, and tolerability in clinical trials. Due to the existence of 2 stereocentres, there are 4 possible stereoisomers for terconazole.
Indication
For the treatment of candidiasis (a yeast-like fungal infection) of the vulva and vagina.
Associated Conditions
- Vulvovaginal Candidiasis
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.